Dental Bone Graft Substitutes Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.80 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Dental Bone Graft Substitutes Market Analysis
The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.
The COVID-19 pandemic has impacted industries worldwide. As all healthcare providers were engaged with COVID-19 management, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care was substantially decreased. Moreover, in March 2020, an ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.
Furthermore, the significant factors responsible for the market's growth include the rising demand for medical and dental tourism; the increasing burden of dental diseases; and technological advancements in dentistry. The rising burden of dental diseases is driving the market's growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.
To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market's growth. As per a May 2020 published study titled "Global Prevalence of Periodontal Disease and Lack of Its Surveillance," periodontitis was most common in older people and populations from high-income countries. The distribution varied significantly between low-income (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income (43.7%) countries. Additionally, according to the International Dental Journal's article titled, "Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study," published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.
Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.
Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, expensive dental procedures and reimbursement issues hinder the market's growth.
Dental Bone Graft Substitutes Market Trends
This section covers the major market trends shaping the Dental Bone Graft Substitutes Market according to our research experts:
The Xenogaft Segment is Expected to Grow Over the Forecast Period
The xenograft segment is expected to hold a significant market share by type. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry. A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, and Pepgen-P15, among others. As xenograft are most affordable, the key players in the market are taking initiatives to launch new products.
For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (CDSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment's growth.
Additionally, the strategic initiatives taken by the market players are also contributing to the growth of the market. For instance, in September 2021, Neoss signed an agreement with Purgo Biologics and became a key partner and distributor of the Purgo Xenograft product range for dental implant solutions in the German, Swedish, and United Kingdom markets.
Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the global dental bone graft substitutes market. The United States is likely to hold a significant market share in the North American region. The major factors contributing to the market's growth are strategic initiatives undertaken by the market players and the growing number of dental visits.
For instance, according to the Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth. Also, as per December 2020 statistics by the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults have untreated tooth decay, and nearly half (46%) of all adults aged 30 years or older show signs of gum disease; and severe gum disease affects about 9% of adults in the United States. These statistics indicate that the percentage of the population visiting dental clinics for examinations contributes to the market's growth.
Moreover, the growing number of strategic initiatives such as product launches, approvals, acquisitions, mergers, partnerships, and joint ventures are anticipated to boost regional growth. For instance, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in the United States, Canada, and several other countries.
Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.
Dental Bone Graft Substitutes Industry Overview
The dental bone graft substitutes market is highly competitive, with several players worldwide. In terms of market share, few significant players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the market's major players are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.
Dental Bone Graft Substitutes Market Leaders
-
Johnson & Johnson
-
Institut Straumann AG
-
Medtronic PLC
-
Dentsply Sirona
-
ZimVie Inc
*Disclaimer: Major Players sorted in no particular order
Dental Bone Graft Substitutes Market News
- In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
- In March 2022, CGbio signed a five-year contract worth KRW 10 billion with Kerunxi Medical, a Chinese specializing in dental equipment, for the export of Bongros Dental, a bone graft material.
Dental Bone Graft Substitutes Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Demand of Medical and Dental Tourism
- 4.2.2 Rising Burden of Dental Diseases
- 4.2.3 Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Expensive Dental Procedures
- 4.3.2 Reimbursement Issues
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Xenograft
- 5.1.2 Allograft
- 5.1.3 Autograft
- 5.1.4 Other Types
-
5.2 By Mechanism
- 5.2.1 Osteoconduction
- 5.2.2 Osteoinduction
- 5.2.3 Osteogenesis
- 5.2.4 Osteopromotion
-
5.3 By End Users
- 5.3.1 Hospitals
- 5.3.2 Dental Clinics
- 5.3.3 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Dentsply Sirona
- 6.1.2 Johnson & Johnson
- 6.1.3 Institut Straumann AG
- 6.1.4 Medtronic PLC
- 6.1.5 ZIMMER BIOMET
- 6.1.6 Geistlich Pharm
- 6.1.7 Dentium
- 6.1.8 LifeNet Health
- 6.1.9 Collagen Matrix Inc.
- 6.1.10 Halma plc (Novabone LLC)
- 6.1.11 Botiss biomaterials GmbH
- 6.1.12 Wright Medical Group NV
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityDental Bone Graft Substitutes Industry Segmentation
As per the scope of this report, a bone graft is used to fix problematic joints or damaged ones, which helps grow bone around the implant. Bone grafting is performed before dental implants to restore missing teeth. Moreover, dentistry uses bone grafts as fillers and scaffolds to facilitate bone formation and promote wound healing. They have no antigen-antibody reaction and are biodegradable. The dental bone grafts develop a new bone that acts as a mineral reservoir. The dental bone graft substitutes market is segmented by product type (xenograft, allograft, autograft, and other types), the mechanism (osteoconduction, osteoinduction, osteogenesis, and osteopromotion), end users (hospitals, dental clinics, and other end users), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (USD million) for the above segments.
| By Type | Xenograft | |
| Allograft | ||
| Autograft | ||
| Other Types | ||
| By Mechanism | Osteoconduction | |
| Osteoinduction | ||
| Osteogenesis | ||
| Osteopromotion | ||
| By End Users | Hospitals | |
| Dental Clinics | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Dental Bone Graft Substitutes Market Research FAQs
What is the current Global Dental Bone Graft Substitutes Market size?
The Global Dental Bone Graft Substitutes Market is projected to register a CAGR of 6.80% during the forecast period (2024-2029)
Who are the key players in Global Dental Bone Graft Substitutes Market?
Johnson & Johnson, Institut Straumann AG, Medtronic PLC, Dentsply Sirona and ZimVie Inc are the major companies operating in the Global Dental Bone Graft Substitutes Market.
Which is the fastest growing region in Global Dental Bone Graft Substitutes Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Dental Bone Graft Substitutes Market?
In 2024, the North America accounts for the largest market share in Global Dental Bone Graft Substitutes Market.
What years does this Global Dental Bone Graft Substitutes Market cover?
The report covers the Global Dental Bone Graft Substitutes Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Dental Bone Graft Substitutes Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Dental Bone Graft Substitutes Industry Report
Statistics for the 2023 Dental Bone Graft Substitutes market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Dental Bone Graft Substitutes analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
